| 1 | DVBCWEM1 ;ALB/CMM ENDOCRINE MISC. DISEASES WKS TEXT - 1 ; 5 MARCH 1997 | 
|---|
| 2 | ;;2.7;AMIE;**12**;Apr 10, 1995 | 
|---|
| 3 | ; | 
|---|
| 4 | ; | 
|---|
| 5 | TXT ; | 
|---|
| 6 | ;;A.  Review of Medical Records: | 
|---|
| 7 | ;; | 
|---|
| 8 | ;; | 
|---|
| 9 | ;; | 
|---|
| 10 | ;;B.  Medical History (Subjective Complaints): | 
|---|
| 11 | ;; | 
|---|
| 12 | ;;     Comment on: | 
|---|
| 13 | ;;     1.  Date of diagnosis and how established. | 
|---|
| 14 | ;; | 
|---|
| 15 | ;; | 
|---|
| 16 | ;;     2.  Fatigability. | 
|---|
| 17 | ;; | 
|---|
| 18 | ;; | 
|---|
| 19 | ;;     3.  Headaches. | 
|---|
| 20 | ;; | 
|---|
| 21 | ;; | 
|---|
| 22 | ;;     4.  Changes in vision. | 
|---|
| 23 | ;; | 
|---|
| 24 | ;; | 
|---|
| 25 | ;;     5.  Neurologic, cardiovascular, or gastrointestinal symptoms. | 
|---|
| 26 | ;; | 
|---|
| 27 | ;; | 
|---|
| 28 | ;;     6.  Treatments (surgery, medications, hormones), including dose, | 
|---|
| 29 | ;;         frequency, response, side effects.  For malignancy, provide | 
|---|
| 30 | ;;         date of completion of treatment for malignancy. | 
|---|
| 31 | ;; | 
|---|
| 32 | ;; | 
|---|
| 33 | ;;     7.  Weight gain or loss. | 
|---|
| 34 | ;; | 
|---|
| 35 | ;; | 
|---|
| 36 | ;;     8.  Excessive thirst, frequency of urination. | 
|---|
| 37 | ;; | 
|---|
| 38 | ;; | 
|---|
| 39 | ;;     9.  Describe the effects of the condition(s) on the veteran's | 
|---|
| 40 | ;;         usual occupation and daily activities. | 
|---|
| 41 | ;; | 
|---|
| 42 | ;; | 
|---|
| 43 | ;;C.  Physical Examination (Objective Findings): | 
|---|
| 44 | ;; | 
|---|
| 45 | ;;    Address each of the following and fully describe current findings: | 
|---|
| 46 | ;;    1.  For hypoparathyroidism, thyroid surgery scar? | 
|---|
| 47 | ;; | 
|---|
| 48 | ;; | 
|---|
| 49 | ;;    2.  For diabetes insipidus, signs of dehydration? | 
|---|
| 50 | ;; | 
|---|
| 51 | ;; | 
|---|
| 52 | ;;    3.  For Addison's disease, muscle strength, blood pressure, skin | 
|---|
| 53 | ;;        pigmentary changes.  Number of crises (with peripheral vascular | 
|---|
| 54 | ;;        collapse) or episodes (less acute and severe than crisis - no | 
|---|
| 55 | ;;        peripheral vascular collapse). | 
|---|
| 56 | ;; | 
|---|
| 57 | ;; | 
|---|
| 58 | ;;    4.  For pluriglandular syndromes, see examinations for glands affected. | 
|---|
| 59 | ;; | 
|---|
| 60 | ;; | 
|---|
| 61 | ;;    5.  Describe all residuals of benign or malignant neoplasm, | 
|---|
| 62 | ;;        including those related to treatment. | 
|---|
| 63 | ;; | 
|---|
| 64 | ;; | 
|---|
| 65 | ;;    6.  Is the disease active or in remission? | 
|---|
| 66 | ;; | 
|---|
| 67 | ;; | 
|---|
| 68 | ;;    7.  For hyperparathyroidism, history of kidney stones.  History | 
|---|
| 69 | ;;        demineralization of skeleton. | 
|---|
| 70 | ;; | 
|---|
| 71 | ;; | 
|---|
| 72 | ;;D.  Diagnostic and Clinical Tests: | 
|---|
| 73 | ;; | 
|---|
| 74 | ;;    Provide, as appropriate/as needed to establish diagnosis: | 
|---|
| 75 | ;;    1.  Blood and urinary calcium. | 
|---|
| 76 | ;;    2.  X-ray of bones to confirm decalcification. | 
|---|
| 77 | ;;    3.  Glucose tolerance test, if necessary. | 
|---|
| 78 | ;;    4.  Antidiuretic hormone level. | 
|---|
| 79 | ;;    5.  Serum and urine electrolytes. | 
|---|
| 80 | ;;    6.  Urine specific gravity. | 
|---|
| 81 | ;;    7.  Serum cortisol. | 
|---|
| 82 | ;;    8.  Serum creatinine. | 
|---|
| 83 | ;;    9.  Serum glucose. | 
|---|
| 84 | ;;   10.  ACTH test. | 
|---|
| 85 | ;;   11.  Include results of all diagnostic and clinical tests conducted | 
|---|
| 86 | ;;        in the examination report. | 
|---|
| 87 | ;; | 
|---|
| 88 | ;; | 
|---|
| 89 | ;; | 
|---|
| 90 | ;;E.  Diagnosis: | 
|---|
| 91 | ;; | 
|---|
| 92 | ;; | 
|---|
| 93 | ;;Signature:                             Date: | 
|---|
| 94 | ;;END | 
|---|